Catalyst Clinical Research Announces Acquisition of Genpro Research

Published on: 

Catalyst Clinical Research announced it has acquired Genpro Research, a Massachusetts-based global clinical research organization with staff in the US, India, and Ireland.

Genpro is a services and technology partner for the pharmaceutical, biotechnology, and medical devices industry with expertise in biometrics, medical writing, RWE, and AI-enabled automation product development. Genpro will continue to be led by Sachin Marulkar, MD, MPH, MBA and the existing management team.

This acquisition adds more than 120 team members in India with expertise in biometrics and medical writing. This further enables biopharma, MedTech and CRO clients (current and future) to access Catalyst's clinical research services, along with broader expertise in global time zones, new solutions, and early access to innovative automation platforms.



Catalyst Clinical Research Announces the Acquisition of Genpro Research. (2023, July 21). Cision PR Newswire.